Tag Archives: Leukemia

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Breakthrough Leukemia Treatment Backfires in a Rare Case

The patient who died had B-cell acute lymphoblastic leukemia that had relapsed several times after standard treatments, and was being treated at the Children’s Hospital of Philadelphia. The university declined to say when he was treated, to protect patient privacy. But the study he joined enrolled patients from August 2011 until September 2016. Once he… Read More »